Title: Import Zelboraf Vemurafenib in India
1A brief medical study of Zelboraf (Vemurafenib)
about its usage
Zelboraf (Vemurafenib) is used to treat skin
cancer or melanoma, spreading to other parts of
the body that can't be removed by surgery. The
medicine is also used to treat rare blood cancer
or Erdheim-Chester Disease. Since the medicine is
used for treatment of blood cancer and not always
available in India, it is essential to import
Zelboraf Vemurafenib in India. The Zelboraf is
used only if cancer has a specific genetic marker
(BRAF gene). Your physician would test you for
this type of gene.
2Import Zelboraf Vemurafenib in India
Warning The medicine is used to treat melanoma,
but the medicine could increase the risk of
developing other types of skin cancers. It is
required to be reported to the physician or the
medical personal right away, when you start
having skin lesions. (Note Many drugs interact
with vemurafenib. So, before starting the
medicines, please tell the physician about the
current medicines.) Before taking the
medicine Zelboraf should not be taken if you
are allergic to it. To ensure that the medicine
works for you, do tell the physician if you ever
had Kidney or liver disease Long QT
syndrome Heart problem Electrolyte
imbalance or The record of having the
radiation treatment.
3Visit Us https//synergydrugs.com/
- Zelboraf should be taken exactly as prescribed by
the physician. It is essential to follow all the
prescription label. Don't take medicine in
smaller or larger amounts or for longer than
recommended. - You can take the medicine with food or without
it, but should have a glass full of water while
taking medicine. - The medicine should be taken every 12 hours, at
the same time every day. - The medicine should not be crushed or broken it
should be swollen whole. - After prolonged usage, you might require a blood
test to check the kidney or liver function.
4Import Zelboraf Vemurafenib in India
- Dosage information
- The usual adult dose of Metastatic melanoma
- The maintenance dose 960 mg is orally given in
every 12 hours with or without the meal. - Duration of the therapy Treatment of the
patients until the progression of the disease or
there is unacceptable toxicity occurs.
5Visit Us https//synergydrugs.com/
Comments Confirmation of the BRAF V600E mutation
in the tumor specimens before the initiation
phase of the treatment phase. Only then, this
medicine would be advised. The missed dose may
be taken up to 4 hours before the next dose. It
is essential to know that there should be no
additional dose taking if vomiting happens after
the dosage. It should be continued with the next
scheduled dose.
6A brief medical study of Zelboraf (Vemurafenib)
about its usage
Email Us access_at_synergydrugs.com Call Us 91
9677010046 Visit Us https//synergydrugs.com/